Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2081-2100 of 3,190 trials

Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients

NCT00574197

Mycophenolate sodium (Myfortic®) is a newly developed enteric-coated tablet version of mycophenolate mofetil (Cellcept®) which is currently used as therapy for the prevention of transplant rejection. Myfortic® was developed to improve the gastrointestinal tolerability of Cellcept®. The new enteric-coated, Myfortic® is presently FDA approved for the prevention of acute kidney rejection only. There is no clinical data of its use in heart transplant patients.

Gastrointestinal SymptomsHeart Transplantation

Cedars-Sinai Medical Center11 participantsStarted Jun 2006

Los Angeles, California, United States

COMPLETEDNA< 1 mile

PREMIUM Migraine Trial

NCT00355056

The Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (PFO) (a hole in the heart), using the AMPLATZER PFO Occluder, on the incidence of migraine headaches.

Migraine HeadachesPatent Foramen Ovale

Abbott Medical Devices230 participantsStarted Jan 2006

Phoenix, Arizona, United States • Los Angeles, California, United States • Colorado Springs, Colorado, United States +27 more locations

Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients

PREMIUM Migraine Trial

Rheumatoid Arthritis Trials in Other Cities

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury

CNS10-NPC-GDNF for the Treatment of ALS

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Improving Quality Vision Outcomes in Managed Care Setting While Reducing Cost by Use of Accurate, Automated Screening

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Study of the Penumbra Coil 400 System to Treat Aneurysm

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Viral Triggers in Pediatric Lung Transplantation

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

Other Conditions in Los Angeles